| Financial Year |
March 31 2023 |
| Monetary Funds |
5,152,344,325.81 |
| Held-for-trading Financial Assets |
729,335,879.16 |
| Notes Receivable |
8,870,760.00 |
| Accounts Receivable |
3,098,046,802.22 |
| Advances to Suppliers |
288,800,211.64 |
| Other Receivables |
1,167,348,099.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,761,954,840.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
11,813,181.78 |
| Other Current Assets |
63,143,007.60 |
| Total Current Assets |
12,721,834,961.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
360,678,822.09 |
| Investment Properties |
-- |
| Fixed Assetes |
5,805,111,468.81 |
| Under-construction Projects |
386,393,740.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
12,176,299.19 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
213,253,772.31 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
79,294,323.01 |
| Deferred Income Tax Assets |
71,082,985.90 |
| Other Non-Current Assets |
501,669,916.18 |
| Sub-Total of Non-Current Assets |
8,042,437,045.05 |
| Total Assets |
20,764,272,006.32 |
| Short-Term Loans |
428,669,344.53 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,035,362,199.84 |
| Accounts Payable |
1,148,236,075.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
94,019,579.84 |
| Taxes Payable |
112,853,936.67 |
| Interest Payable |
-- |
| Dividend Payable |
6,280,000.00 |
| Other payables |
221,673,187.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
356,326,464.17 |
| Other Current Liabilities |
6,080,649.05 |
| Sub-Total of Current Liabilities |
3,724,787,057.95 |
| Long-term Loans |
1,611,524,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
27,827,219.41 |
| Deferred Income Tax Liabilities |
11,587,405.44 |
| Other Non-Current Liabilities |
11,658,816.07 |
| Sub-Total of Non-Current Liabilities |
2,012,984,803.66 |
| Total Liabilities |
5,737,771,861.61 |
| Paid-In Capital(Or Share Stock) |
2,060,169,156.00 |
| Capital Surplus |
7,589,336,189.45 |
| Surplus Reserve |
401,150,539.59 |
| LESS:Treasury Stock |
278,835,134.67 |
| Undistributed Profits |
5,166,553,680.64 |
| Minority Stockholder's Interest |
87,068,573.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,939,431,570.95 |
| Owner's Equity（Stockholder's Equity） |
15,026,500,144.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,764,272,006.32 |
